San Diego, October 8, 2018. CHIPSA Hospital, an integrative cancer hospital in Mexico, hosted an inaugural Scientific Forum and Survivors Reunion at the Town and Country Resort in San Diego on Thursday September 27, 2018. The event brought over twenty long-term cancer survivors (many with over 20 years of remission from Stage 4 cancer) and connected […]
Continue reading
In what many are hailing as a paradigm shift in the treatment of cancer, The Nobel Prize in Physiology or Medicine was awarded to James P. Allison of the United States and Tasuku Honjo of Japan for their cutting-edge, exceptional work in developing cancer immunotherapy treatments. Allison, age 70, is from Alice, Texas and currently […]
Continue reading
Join Us For a Celebration of Life. Honoring Those Patients Who Chose A Non-Traditional Path in Treating Their Cancer!Learn How CHIPSA is Combining New Cutting Edge Therapies With The Power of the Mind and Gerson Therapy In Their Quest To Find A Cure For Cancer.Tickets are still Available. Click the orange button below. CLICK HERE […]
Continue reading
Cancer is defined by cell cycle deregulation and uncontrolled growth. It is the second leading cause of death in the world. In the United States alone there were 1,658,370 new cancer cases diagnosed and 589,430 cancer deaths and an estimated 750,000 deaths in Europe. We are fighting a losing battle. But we now have a […]
Continue reading
A recent study performed by AstraZeneca and MedImmue reveals, provisionally, that a Phase III trial with the drug Imfinzi, also known as durvalumab, gives longer life to patients with advanced, inoperable, non-small cell lung cancer (NSCLC). The trial, known as PACIFIC Phase 3, tests Imfinzi in comparison to placebo drugs in patients […]
Continue reading
Dear Friends, So far 2018 has been a year of great gains in our treatment of cancer at The CHIPSA Hospital. The CHIPSA Approach™ has been a simple one; forget our ego and preconceived notions of what works in treating cancer and be open to all possibilities. This includes considering both natural and man made […]
Continue reading
Vallovax and CHIPSAIn October of 2017 Chipsa was introduced to Batu Biologics, a San Diego based Biotech company, whose mission aligned with Chipsa’s. How can we harness the power of the immune system to treat cancer? Batu Biologics presented us with a novel therapy. A blood based vaccine that sought to target what many see as […]
Continue reading
CHIPSA is excited to announce that 2011 Nobel prize winner Bruce Beutler has joined the board of one of our key collaborators, Batu Biologics. CHIPSA has been on the forefront of immunotherapy for nearly 38 years and the addition to Dr. Beutler on the Scientific Advisory board of Batu is another signal that Immunotherapy is […]
Continue reading
Immuno-oncology is set to become one of the most vital cancer treatments, rising up into the realms surgery, chemotherapy, radiotherapy, and other targeted therapies. From their study, “Pharma Focus Visual Analysis of Immuno-Oncology Development and Opportunities”, Global Data was able to reach a conclusion and has analyzed more than 4,000 clinical trials of over 800 […]
Continue reading
A mouse study published in Cell Chemical Biology reveals that a new version of the foreign fat molecule alpha-galactosylceramide (a-GalCer) is very successful at inducing inflammatory and anti-tumor responses in humans. The results of this study may be helpful in creating treatments that will prevent the spread of cancer. Past studies have shown that synthetic-GalCer, […]
Continue reading